W. R. Berkley Corporation Names Kirk A. Parker President of Berkley North Pacific

GREENWICH, Conn.--(BUSINESS WIRE)-- W. R. Berkley Corporation (NYSE: WRB) today announced the appointment of Kirk A. Parker as president of Berkley North Pacific. The appointment is effective immediately.

Mr. Parker has nearly 30 years of leadership experience in the property and casualty insurance industry focused on optimizing operations and accelerating profitable growth across distribution networks. He most recently served as senior vice president and regional president at a large, national multi-line insurer.

Commenting on the appointment, W. Robert Berkley, Jr., chairman, chief executive officer and president, of W. R. Berkley Corporation, said: "We are pleased to welcome Kirk as president of Berkley North Pacific. He is a proven insurance leader with broad operating experience and a strong track record. We look forward to him working closely with our agents and associates as Berkley North Pacific.”

Berkley North Pacific provides tailored insurance solutions through empowered, local decision-makers through a select group of independent agents in Idaho, Montana, Oregon, Utah, and Washington. For further information about the products and services available from Berkley North Pacific, please visit www.berkleynpac.com.

Founded in 1967, W. R. Berkley Corporation is an insurance holding company that is among the largest commercial lines writers in the United States and operates worldwide in two segments of the property casualty insurance business: Insurance and Reinsurance & Monoline Excess. For further information about W. R. Berkley Corporation, please visit www.berkley.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260610636111/en/

Karen A. Horvath
Vice President – External
Financial Communications
203-629-3000

Source: W. R. Berkley Corporation

You May Also Be Interested In

• W. R. Berkley Corporation to Announce Second Quarter 2026 Earnings on July 20, 2026
• Comfort Systems Announces Leadership Transitions and Appointments Effective as of July 1, 2026
• Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer